Alongside a nationwide network of advocates, The Michael J. Fox Foundation works to ensure government policies accelerate the development of new, improved Parkinson's disease (PD) therapies and increase quality of life for people with Parkinson's and their families.
Our public policy work covers three priority areas:
Further Parkinson’s Disease Research
Basic research is the backbone of drug development, and the federal government funds more of this research, through U.S. taxpayers' contributions, than any other entity. Robust federal support is critical to moving better treatments and cures forward.
Federal Research Funding
Sufficient funding for the National Institutes of Health and the Department of Defense is key to driving progress.
PD Data Collection
Increased demographic information about people with Parkinson’s can help researchers refine and target their work.
Access to an array of scientific resources is critical to advancing breakthroughs.
Environmental Risk Factors
Research into chemicals and toxins associated with PD can build greater understanding of disease risk.
Support Therapy Development and Approvals
As new medications and devices approach market, they must request Food and Drug Administration (FDA) approval to be made available to the public. The FDA requires a significant budget to carry out its regulatory responsibilities and protect public health. It's also crucial that the agency understands patient priorities in order to address gaps in the Parkinson’s treatment strategy.
The agency requires adequate staff and resources in order to approve therapies efficiently.
Amplifying Patients' Needs
To bring life-changing treatments to market, the FDA must be in tune with patients’ needs and the latest ways to meet them.
Safeguard Access to Care and Support Services
Access to health services and treatments is an important part of any care regimen. For those living with Parkinson's disease today, these factors directly impact quality of life. Resources such as government benefits, comprehensive insurance coverage and emerging technologies can help improve well-being. To ensure the Foundation’s policy efforts in this area are in line with the patient perspective, The Michael J. Fox Foundation (MJFF) has established a guiding set of health care principles.
Federal Health Programs
Medicare, Medicaid, the Department of Veterans Affairs and the Social Security Administration are vital to helping patients receive care.
The remote delivery of health care services allows more patients to see disease experts and helps conserve costs.
Supports for Care Partners
Individuals caring for a loved one with PD need comprehensive resources to help manage their responsibilities.
How the Public Policy Team Works
The Foundation's Public Policy team elevates the needs of people with Parkinson’s and their loved ones by meeting regularly with members of Congress and federal agency staff in Washington to educate them on issues of importance to the Parkinson’s community. The Foundation also drafts letters to policymakers to push for policies favorable to Parkinson’s research and care. This work may be accomplished independently, through the Unified Parkinson's Advocacy Council (a group of national, regional and state PD organizations that gather input on community priorities), or by partnering with other research- and patient-focused organizations in coalitions. For example, through our memberships in the American Brain Coalition and Partners for Better Care, the Foundation works with like-minded organizations to urge Congress to support patients and families. By collaborating in this way, the voice of the Parkinson’s community is amplified in the policymaking process.